Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call Transcript

2025-02-28 11:57:31 ET

Fulgent Genetics, Inc. (FLGT)

Q4 2024 Earnings Conference Call

February 27, 2025, 08:30 AM ET

Company Participants

Melanie Solomon - IR

Ming Hsieh - Chairman and CEO

Brandon Perthuis - Chief Commercial Officer

Paul Kim - CFO

Conference Call Participants

David Westenberg - Piper Sandler

Lu Li - UBS

Andrew Cooper - Raymond James

Presentation

Operator

Greetings and welcome to the Fulgent Genetics Q4 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions]. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to your host, Melanie Solomon, Investor Relations. Please go ahead.

Melanie Solomon

Thanks, Kevin. Good morning and welcome to the Fulgent's fourth quarter and full-year 2024 financial results conference call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; and Brandon Perthuis, Chief Commercial Officer.

The company's press release discussing the financial results is available on the Investor Relations section of the company's website, ir. fulgentgenetics.com. A replay of this call will be available shortly after the call concludes on the Investor Relations section of the company's website.

Management's prepared remarks and answers to your questions on today's call will contain forward-looking statements. These forward-looking statements represent management's estimates based on current views, expectations, and assumptions, which may prove to be incorrect. As a result, matters discussed in any forward-looking statements are subject to risks, uncertainties, and changes in circumstances that may cause actual results to differ from those described in the forward-looking statements....

Read the full article on Seeking Alpha

For further details see: